Annual Accounts Payable
$167.30 K
0.00%
01 December 2023
Summary:
Cadrenal Therapeutics Common Stock annual accounts payable is currently $167.30 thousandCVKD annual accounts payable is now -58.68% below its all-time high of $404.90 thousand, reached on 31 December 2022.CVKD Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$496.80 K
-$262.70 K-34.59%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock quarterly accounts payable is currently $496.80 thousand, with the most recent change of -$262.70 thousand (-34.59%) on 01 September 2024. Over the past year, it has increased by +$355.10 thousand (+250.60%). CVKD quarterly accounts payable is now -34.59% below its all-time high of $759.50 thousand, reached on 01 June 2024.CVKD Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CVKD Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.7% | +250.6% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CVKD Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.7% | at low | -34.6% | +536.1% |
| 5 y | 5 years | -58.7% | at low | -34.6% | +536.1% |
| alltime | all time | -58.7% | at low | -34.6% | +536.1% |
Cadrenal Therapeutics Common Stock Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $496.80 K(-34.6%) |
| June 2024 | - | $759.50 K(+89.7%) |
| Mar 2024 | - | $400.40 K(+139.3%) |
| Dec 2023 | $167.30 K | $167.30 K(+18.1%) |
| Sept 2023 | - | $141.70 K(+81.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $78.10 K(-34.7%) |
| Mar 2023 | - | $119.60 K(-70.5%) |
| Dec 2022 | $404.90 K | $404.90 K(+31.4%) |
| Sept 2022 | - | $308.20 K(+48.5%) |
| June 2022 | - | $207.50 K |
FAQ
- What is Cadrenal Therapeutics Common Stock annual accounts payable?
- What is the all time high annual accounts payable for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock annual accounts payable year-on-year change?
- What is Cadrenal Therapeutics Common Stock quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly accounts payable year-on-year change?
What is Cadrenal Therapeutics Common Stock annual accounts payable?
The current annual accounts payable of CVKD is $167.30 K
What is the all time high annual accounts payable for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high annual accounts payable is $404.90 K
What is Cadrenal Therapeutics Common Stock annual accounts payable year-on-year change?
Over the past year, CVKD annual accounts payable has changed by -$237.60 K (-58.68%)
What is Cadrenal Therapeutics Common Stock quarterly accounts payable?
The current quarterly accounts payable of CVKD is $496.80 K
What is the all time high quarterly accounts payable for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high quarterly accounts payable is $759.50 K
What is Cadrenal Therapeutics Common Stock quarterly accounts payable year-on-year change?
Over the past year, CVKD quarterly accounts payable has changed by +$355.10 K (+250.60%)